NTLA
Intellia Therapeutics, Inc.Healthcare$13.13
▲ Bullish
Mkt Cap: $1.55B|Float: 111.9M|SI: 35.2%|DTC: 9.9
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
49.5%
52W Range
$6-$28
ATR(14)
$0.79
Exp. Move
±15.6%
P/C Ratio
0.31
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
NTLA Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $3.7M
- Max Pain
- $12.50
- Expected Move
- ±15.6%
- Put/Call OI
- 0.31
- Net Premium
- $1.1M
- Spot Price
- $13.13
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.05 | ±15.6% | $11.08 | $15.18 |
| 2026-05-15 | 43 | ±$3.48 | ±26.5% | $9.66 | $16.61 |
| 2026-07-17 | 106 | ±$6.33 | ±48.2% | $6.81 | $19.46 |
| 2026-09-18 | 169 | ±$6.85 | ±52.2% | $6.28 | $19.98 |
| 2026-10-16 | 197 | ±$8.12 | ±61.9% | $5.01 | $21.26 |
| 2027-01-15 | 288 | ±$9.40 | ±71.6% | $3.73 | $22.53 |
Explore NTLA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.